Blood Glucose Testing Frequency Correlates to A1c Reduction After 3 Months of Insulin Titration Utilizing Glucommander Presentation International Conference on Advanced Technologies & Treatments for Diabetes Date February 2018 Authors Bruce Bode, John Clarke, Andrew Rhinehart, Robby Booth BACKGROUND Effective basal bolus insulin therapy requires dose titration to identify the right doses for each individual patient. Self-monitoring of blood glucose …
February 15, 2017
Time To Target Using eGMS To Manage Inpatient Subcutaneous Insulin Basal Bolus Regimen
Time To Target Using eGMS To Manage Inpatient Subcutaneous Insulin Basal Bolus Regimen Presentation International Conference on Advanced Technologies & Treatments for Diabetes Date February 2017 Authors Bruce Bode,1 Courtenay Harrison2 OBJECTIVE The importance of inpatient glycemic control on outcomes not only applies to patients managed with IV insulin in critical care areas but also patients on general surgical and …
Glucommander Outpatient, a Cloud-Based Insulin Management Solution, Titrated Patients to Goal in 11 Days and Sustained a 2.6% Drop in HBA1C Over 6 Months
Glucommander Outpatient, A Cloud-Based Insulin Management Solution, Titrated Patients to Goal in 11 Days and Sustained a 2.6% Drop in HBA1C Over 6 Months Presentation International Conference on Advanced Technologies & Treatments for Diabetes Date February 2017 Authors Bruce Bode,1 John Clarke1 BACKGROUND Treatment of diabetes with multiple daily injections (MDI), using a regimen of long-acting basal and rapid-acting bolus …
